CI Canadian Convertible Bond ETF Common (TSE:CXF – Get Free Report)’s share price fell 0.5% during trading on Tuesday . The company traded as low as C$9.76 and last traded at C$9.85. 26,083 shares changed hands during trading, an increase of 455% from the average session volume of 4,697 shares. The stock had previously closed at C$9.90.
CI Canadian Convertible Bond ETF Common Price Performance
The firm has a 50 day moving average of C$10.10 and a two-hundred day moving average of C$10.11.
CI Canadian Convertible Bond ETF Common Company Profile
Chimerix, Inc, a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company’s approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox.
See Also
- Five stocks we like better than CI Canadian Convertible Bond ETF Common
- Which Wall Street Analysts are the Most Accurate?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Ride Out The Recession With These Dividend Kings
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for CI Canadian Convertible Bond ETF Common Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CI Canadian Convertible Bond ETF Common and related companies with MarketBeat.com's FREE daily email newsletter.
